Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Results presented from pilot study of Panvac vaccine

Dec. 19, 2011

Wilex discusses development of Redectane with FDA

Dec. 16, 2011

Kyowa Hakko Kirin presents novel kynurenine production inhibitors

Dec. 16, 2011

Onyx Pharmaceuticals joins MMRF's personalized medicine initiative

Dec. 16, 2011

Phase II data encourage further development of aminopeptidase N inhibitor in leukemia

Dec. 16, 2011

GSK files for Japanese approval of oral kinase inhibitor in malignant soft tissue sarcoma

Dec. 16, 2011

Threshold reports encouraging results from ongoing TH-302 trial in advanced leukemias

Dec. 16, 2011

PARP inhibitor shows promise combined with temozolomide in advanced solid tumors

Dec. 16, 2011

PANORAMA 1 study evaluates panobinostat in multiple myeloma

Dec. 16, 2011

Novel protein kinase inhibitors reported

Dec. 16, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...